Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer?
We just covered the Jim Cramer Stock Portfolio: Top 10 Stock Picks. Eli Lilly and Company (NYSE:LLY) ranks…
We’re dipping into our large cash pile to buy more of this health-care stock
We are buying 90 shares of Cardinal Health at roughly $217. Following the trade, Jim Cramer’s Charitable Trust…
Eli Lilly’s lead in the obesity race gets wider after win against Novo
In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…
Jim Cramer says the software sell-off creates opportunities in stocks outside of tech
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
Microsoft’s $440 billion wipeout, and investors angry about OpenAI’s debt, explained
Wall Street’s yearslong bet on AI is facing a severe test on Thursday, as investors might begin to…
Another alliance of health care and AI signals why pharma stocks could be back
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the…
Jim Cramer says achieving early retirement comes down to just 3 key assets in your investment portfolio
If early retirement is something you’re striving for, you’re not alone. A 2024 YouGov survey found that 22%…
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
We’re increasing price targets on our bank stocks after their strong runs
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Stocks rebound, subprime worries persist, and Friday brings inflation data despite shutdown
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Jim Cramer’s top 10 things to watch in the stock market Thursday
My top 10 things to watch Thursday, Oct. 23 1. Wall Street was headed for a lower open…
We’re downgrading it, considering next move
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue…